Arash Maleki is an Ophthalmology physician affiliated with Historic Deerfield. OpenAlex indexes 84 publications with 682 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
20 Southbridge Rd
Charlton, MA 015075235
Telephone
508-765-9068Provider last certified this registry record 12 Feb 2026.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20253 payments
- Mallinckrodt Hospital Products Inc.Program year20252 payments
- ANI Pharmaceuticals, Inc.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
54.7%Corticosteroid17%Prednisolone Acetate100%Part D≥20 patientsCarbonic Anhydrase Inhibitor16.1%Dorzolamide Hcl64%Dorzolamide-Timolol36%Part D<11 patients+ 3 more classes in this area
Cancer & immunology
22.4%Folate Analog Metabolic Inhibitor8.5%Methotrexate100%Part D<11 patientsTNF inhibitor7.2%Humira(Cf) Pen100%Part D<11 patients+ 1 more class in this area
Anti-infectives
9%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor9%Valacyclovir100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Approaching ramp lesions from the different world of posterior knee compartment: A review of evidence with a proposal of a new classification and treatment
Journal of Experimental Orthopaedics
2024 - Bilateral Optic Neuropathy Secondary to Intravenous Carboplatin Therapy
Journal of Ophthalmic and Vision Research
2024 - Updates on Systemic Immunomodulation in Peripheral Ulcerative Keratitis
Journal of Clinical & Translational Ophthalmology
2024 - Paracentral acute middle maculopathy and cotton wool spots in a patient with ocular migraine: A case report
European Journal of Ophthalmology
2024 - Cogan-Like Syndrome Following Nivolumab Immunotherapy for Metastatic Cutaneous Melanoma
Ocular Immunology and Inflammation
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”